Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study

Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France

(2018) Pierre-Olivier Blotière et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Use of state sequence analysis for care pathway analysis: The example of multiple sclerosis

(2018) Jonathan Roux et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Health care services and disease modifying therapies use in community-based multiple sclerosis patients: Evolution from 2013 to 2015 and demographic characteristics

(2018) Philippe Ha-Vinh et al.   PRESSE MEDICALE

Update on disease-modifying therapies for multiple sclerosis

(2017) Diana L Vargas et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data

(2017) Stéphanie Foulon et al.   JOURNAL OF NEUROLOGY

Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France

(2017) P. Tuppin et al.   REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE

The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality

(2016) Aurélie Bannay et al.   MEDICAL CARE

What matters in differences between life trajectories: a comparative review of sequence dissimilarity measures

(2015) Matthias Studer et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

Analyzing and Visualizing State Sequences inRwithTraMineR

(2015) Alexis Gabadinho et al.   Journal of Statistical Software

Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients

(2009) M Debouverie et al.   Multiple Sclerosis Journal